Title:
Team Grant: CIHR-JDRF-Accelerating Stem Cell-Based Therapies for Type 1 Diabetes
Agreement Value:
$1,494,952.00
Agreement Date:
Dec 1, 2020 - Nov 30, 2025
Description:
The specific objectives of this funding opportunity are:
• To strengthen and create new, Canadian-led multidisciplinary collaborations among researchers working in stem cell biology, immunology and related fields to advance knowledge and technologies relevant to beta cell replacement in T1D.
• To accelerate potential stem cell-based therapies for T1D to the preclinical or clinical trial stage.
Organization:
Canadian Institutes of Health Research
Expected Results:
This program provides funding for targeted grants and awards aimed at addressing priority areas. Priorities are identified by CIHR in consultation with other government departments and agencies, partners and stakeholders. The program mobilizes researchers, patients, health providers, and decision makers to conduct research, enable knowledge translation and build capacity in the priority areas. It often requires collaboration within and across sectors.
Location:
Vancouver, British Columbia, CA V6T 1Z1
Reference Number:
236-2020-2021-Q3-00361
Report Type:
Grants and Contributions
Recipient Type:
Individual or sole proprietorship
Recipient's Legal Name:
Lynn, Francis C
Research Organization:
University of British Columbia
Program:
Research in Priority Areas
Program Purpose:
This program provides funding for targeted grants and awards aimed at addressing priority areas. Priorities are identified by CIHR in consultation with other government departments and agencies, partners and stakeholders. The program mobilizes researchers, patients, health providers, and decision makers to conduct research, enable knowledge translation and build capacity in the priority areas. It often requires collaboration within and across sectors.